Robey RW - Search Results

1

Flow cytometric analysis of breast cancer resistance protein expression and function.

Minderman H, Suvannasankha A, O'Loughlin KL, Scheffer GL, Scheper RJ, Robey RW, Baer MR. Minderman H, et al. Among authors: robey rw. Cytometry. 2002 Jun 1;48(2):59-65. doi: 10.1002/cyto.10111. Cytometry. 2002. PMID: 12116365 Free article.

2

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE. Wosikowski K, et al. Among authors: robey rw. Cell Growth Differ. 1995 Nov;6(11):1395-403. Cell Growth Differ. 1995. PMID: 8562478

3

Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein.

Gudas JM, Nguyen H, Li T, Sadzewicz L, Robey R, Wosikowski K, Cowan KH. Gudas JM, et al. Carcinogenesis. 1996 Jul;17(7):1417-27. doi: 10.1093/carcin/17.7.1417. Carcinogenesis. 1996. PMID: 8706243

4

Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.

Lee JS, Scala S, Matsumoto Y, Dickstein B, Robey R, Zhan Z, Altenberg G, Bates SE. Lee JS, et al. J Cell Biochem. 1997 Jun 15;65(4):513-26. J Cell Biochem. 1997. PMID: 9178101

5

Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.

Brangi M, Litman T, Ciotti M, Nishiyama K, Kohlhagen G, Takimoto C, Robey R, Pommier Y, Fojo T, Bates SE. Brangi M, et al. Cancer Res. 1999 Dec 1;59(23):5938-46. Cancer Res. 1999. PMID: 10606239

6

Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.

de Bruin M, Miyake K, Litman T, Robey R, Bates SE. de Bruin M, et al. Cancer Lett. 1999 Nov 15;146(2):117-26. doi: 10.1016/s0304-3835(99)00182-2. Cancer Lett. 1999. PMID: 10656616

7

Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

Robey RW, Medina-Pérez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, Bates SE. Robey RW, et al. Clin Cancer Res. 2001 Jan;7(1):145-52. Clin Cancer Res. 2001. PMID: 11205902

8

A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).

Robey RW, Honjo Y, van de Laar A, Miyake K, Regis JT, Litman T, Bates SE. Robey RW, et al. Biochim Biophys Acta. 2001 Jun 6;1512(2):171-82. doi: 10.1016/s0005-2736(01)00308-x. Biochim Biophys Acta. 2001. PMID: 11406094 Free article.

9

Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.

Honjo Y, Hrycyna CA, Yan QW, Medina-Pérez WY, Robey RW, van de Laar A, Litman T, Dean M, Bates SE. Honjo Y, et al. Among authors: robey rw. Cancer Res. 2001 Sep 15;61(18):6635-9. Cancer Res. 2001. PMID: 11559526

10

Reversal of multidrug resistance: lessons from clinical oncology.

Bates SF, Chen C, Robey R, Kang M, Figg WD, Fojo T. Bates SF, et al. Novartis Found Symp. 2002;243:83-96; discussion 96-102, 180-5. Novartis Found Symp. 2002. PMID: 11990784 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters